{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:22:04Z","timestamp":1794864124846,"version":"4.9.1"},"reference-count":150,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2020,12,31]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Parkinson\u2019s disease (PD) has been one of the substantial social, medical concern and, burdens of\nthe present time. PD is a gradually devastating neurodegenerative disorder of the neurological function marked with \u03b1synucleinopathy affecting numerous regions of the brain-gut axis, as well as the central, enteric, and autonomic nervous system. Its etiology is a widely disputed topic.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> This review emphasizes to find out the correlation among the microbial composition and the observable disturbances in the metabolites of the microbial species and its impact on the immune response, which may have a concrete implication on the occurrence, persistence and, pathophysiology of PD via the gut-brain axis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>An in-depth research and the database was developed from the available peer reviewed articles till date (March\n2020) utilizing numerous search engines like PubMed, MEDLINE and, other internet sources.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> Progressively increasing shreds of evidence have proved the fact that dysbiosis in the gut microbiome plays a central role in many neurological disorders, such as PD. Indeed, a disordered microbiome-gut-brain axis in PD could be focused\non gastrointestinal afflictions that manifest primarily several years prior to the diagnosis, authenticating a concept wherein\nthe pathological pathway progresses from the intestine reaching the brain.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The microbiota greatly affects the bidirectional interaction between the brain and the gut via synchronized neurological, immunological, and neuroendocrine mechanisms. It can be concluded that a multitude of factors discussed in this\nreview steadily induce the onset of dysbacteriosis that may exacerbate the etiologic mechanism of Parkinson\u2019s disease. <\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570159x18666200606233050","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T19:37:37Z","timestamp":1591472257000},"page":"233-247","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson\u2019s Disease"],"prefix":"10.2174","volume":"19","author":[{"given":"Gagandeep","family":"Kaur","sequence":"first","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bungau","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Kumar","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Sahab","family":"Uddin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Southeast University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Mehta","sequence":"additional","affiliation":[{"name":"Government College of Pharmacy, Shimla, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Zengin","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Science, Selcuk Uniersity Campus, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijo","family":"Mathew","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Ahalia School of Pharmacy, Palakkad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ajmal","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Arora","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.4103\/0028-3886.226451","volume":"66","author":"Radhakrishnan D.M.","year":"2018","unstructured":"Radhakrishnan D.M.; Goyal V.; Parkinson\u2019s disease: A review. Neurol India 2018,66(Suppl.),S26-S35","journal-title":"Neurol India"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fnagi.2018.00109","volume":"10","author":"Zeng X.S.","year":"2018","unstructured":"Zeng X.S.; Geng W.S.; Jia J.J.; Chen L.; Zhang P.P.; Cellular and molecular basis of neurodegeneration in Parkinson disease. Front Aging Neurosci 2018,10,109 https:\/\/dx.doi.org\/10.3389%2Ffnagi.2018.00109","journal-title":"Front Aging Neurosci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00702-011-0684-8","volume":"119","author":"Desai Bradaric B.","year":"2012","unstructured":"Desai Bradaric B.; Patel A.; Schneider J.A.; Carvey P.M.; Hendey B.; Evidence for angiogenesis in Parkinson\u2019s disease, incidental Lewy body disease, and progressive supranuclear palsy. J Neural Transm (Vienna) 2012,119(1),59-71","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11481-013-9435-y","volume":"8","author":"Blandini F.","year":"2013","unstructured":"Blandini F.; Neural and immune mechanisms in the pathogenesis of Parkinson\u2019s disease. J Neuroimmune Pharmacol 2013,8(1),189-201","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s40473-017-0129-2","volume":"4","author":"Perez-Pardo P.","year":"2017","unstructured":"Perez-Pardo P.; Hartog M.; Garssen J.; Kraneveld A.D.; Microbes tickling your tummy: the Importance of the Gut-Brain axis in parkinson\u2019s disease. Curr Behav Neurosci Rep 2017,4(4),361-368","journal-title":"Curr Behav Neurosci Rep"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/mds.27138","volume":"33","author":"Borghammer P.","year":"2018","unstructured":"Borghammer P.; How does parkinson\u2019s disease begin? Perspectives on neuroanatomical pathways, prions, and histology. Mov Disord 2018,33(1),48-57","journal-title":"Mov Disord"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1590\/0004-282x20170188","volume":"76","author":"Gershanik O.S.","year":"2018","unstructured":"Gershanik O.S.; Does Parkinson\u2019s disease start in the gut? Arq Neuropsiquiatr 2018,76(2),67-70","journal-title":"Arq Neuropsiquiatr"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.expneurol.2017.08.001","volume":"298","author":"Surmeier D.J.","year":"2017","unstructured":"Surmeier D.J.; Halliday G.M.; Simuni T.; Calcium, mitochondrial dysfunction and slowing the progression of Parkinson\u2019s disease. Exp Neurol 2017,298(Pt B),202-209","journal-title":"Exp Neurol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3389\/fneur.2019.01155","volume":"10","author":"Yang D.","year":"2019","unstructured":"Yang D.; Zhao D.; Ali Shah S.Z.; Wu W.; Lai M.; Zhang X.; Li J.; Guan Z.; Zhao H.; Li W.; Gao H.; Zhou X.; Yang L.; The role of the gut microbiota in the pathogenesis of Parkinson\u2019s Disease. Front Neurol 2019,10,1155","journal-title":"Front Neurol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"Braak H.","year":"2003","unstructured":"Braak H.; R\u00fcb U.; Gai W.P.; Del Tredici K.; Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna) 2003,110(5),517-536","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar5280","volume":"10","author":"Killinger B.A.","year":"2018","unstructured":"Killinger B.A.; Madaj Z.; Sikora J.W.; Rey N.; Haas A.J.; Vepa Y.; Lindqvist D.; Chen H.; Thomas P.M.; Brundin P.; Brundin L.; Labrie V.; The vermiform appendix impacts the risk of developing Parkinson\u2019s disease. Sci Transl Med 2018,10(465)","journal-title":"Sci Transl Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.25020","volume":"27","author":"Shannon K.M.","year":"2012","unstructured":"Shannon K.M.; Keshavarzian A.; Dodiya H.B.; Jakate S.; Kordower J.H.; Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s disease? Evidence from 3 cases. Mov Disord 2012,27(6),716-719","journal-title":"Mov Disord"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"Kim S.","year":"2019","unstructured":"Kim S.; Kwon S-H.; Kam T-I.; Panicker N.; Karuppagounder S.S.; Lee S.; Lee J.H.; Kim W.R.; Kook M.; Foss C.A.; Shen C.; Lee H.; Kulkarni S.; Pasricha P.J.; Lee G.; Pomper M.G.; Dawson V.L.; Dawson T.M.; Ko H.S.; Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 2019,103(4),627-641.e7","journal-title":"Neuron"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","volume":"3","author":"Houser M.C.","year":"2017","unstructured":"Houser M.C.; Tansey M.G.; The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis? NPJ Parkinsons Dis 2017,3,3","journal-title":"NPJ Parkinsons Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","volume":"11","author":"Klingelhoefer L.","year":"2015","unstructured":"Klingelhoefer L.; Reichmann H.; Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors. Nat Rev Neurol 2015,11(11),625-636","journal-title":"Nat Rev Neurol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/mds.21560","volume":"22","author":"Abbott R.D.","year":"2007","unstructured":"Abbott R.D.; Ross G.W.; Petrovitch H.; Tanner C.M.; Davis D.G.; Masaki K.H.; Launer L.J.; Curb J.D.; White L.R.; Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord 2007,22(11),1581-1586","journal-title":"Mov Disord"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/ejn.14290","volume":"49","author":"Tansey M.G.","year":"2019","unstructured":"Tansey M.G.; Romero-Ramos M.; Immune system responses in Parkinson\u2019s disease: Early and dynamic. Eur J Neurosci 2019,49(3),364-383","journal-title":"Eur J Neurosci"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.03.014","volume":"135","author":"Sampson T.","year":"2020","unstructured":"Sampson T.; The impact of indigenous microbes on Parkinson\u2019s disease. Neurobiol Dis 2020,135","journal-title":"Neurobiol Dis"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12026-015-8718-1","volume":"63","author":"Pavlov V.A.","year":"2015","unstructured":"Pavlov V.A.; Tracey K.J.; Neural circuitry and immunity. Immunol Res 2015,63(1-3),38-57","journal-title":"Immunol Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"Holmqvist S.","year":"2014","unstructured":"Holmqvist S.; Chutna O.; Bousset L.; Aldrin-Kirk P.; Li W.; Bj\u00f6rklund T.; Wang Z.Y.; Roybon L.; Melki R.; Li J.Y.; Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 2014,128(6),805-820","journal-title":"Acta Neuropathol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/gbb.12109","volume":"13","author":"Stilling R.M.","year":"2014","unstructured":"Stilling R.M.; Dinan T.G.; Cryan J.F.; Microbial genes, brain","journal-title":"Genes Brain Behav"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/978-1-4939-0897-4_17","volume":"817","author":"Borre Y.E.","year":"2014","unstructured":"Borre Y.E.; Moloney R.D.; Clarke G.; Dinan T.G.; Cryan J.F.; The impact of microbiota on brain and behavior: mechanisms","journal-title":"Adv Exp Med Biol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/1871524918666180416153742","volume":"18","author":"Gupta M.","year":"2018","unstructured":"Gupta M.; Kant K.; Sharma R.; Kumar A.; Evaluation of In Silico anti-parkinson potential of \u03b2-asarone. Cent Nerv Syst Agents Med Chem 2018,18(2),128-135","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/ana.10513","volume":"53","author":"Rascol O.","year":"2003","unstructured":"Rascol O.; Payoux P.; Ory F.; Ferreira J.J.; Brefel-Courbon C.; Montastruc J.L.; Limitations of current Parkinson\u2019s disease therapy. Ann Neurol 2003,53(Suppl. 3),S3-S12","journal-title":"Ann Neurol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"Thursby E.","year":"2017","unstructured":"Thursby E.; Juge N.; Introduction to the human gut microbiota. Biochem J 2017,474(11),1823-1836","journal-title":"Biochem J"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.phrs.2012.10.007","volume":"69","author":"Natividad J.M.M.","year":"2013","unstructured":"Natividad J.M.M.; Verdu E.F.; Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol Res 2013,69(1),42-51","journal-title":"Pharmacol Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature18849","volume":"535","author":"B\u00e4umler A.J.","year":"2016","unstructured":"B\u00e4umler A.J.; Sperandio V.; Interactions between the microbiota and pathogenic bacteria in the gut. Nature 2016,535(7610),85-93","journal-title":"Nature"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1126\/science.aad9378","volume":"352","author":"Gensollen T.","year":"2016","unstructured":"Gensollen T.; Iyer S.S.; Kasper D.L.; Blumberg R.S.; How colonization by microbiota in early life shapes the immune system. Science 2016,352(6285),539-544","journal-title":"Science"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"den Besten G.","year":"2013","unstructured":"den Besten G.; van Eunen K.; Groen A.K.; Venema K.; Reijngoud D-J.; Bakker B.M.; The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 2013,54(9),2325-2340","journal-title":"J Lipid Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpg.2016.02.001","volume":"30","author":"Chang C.","year":"2016","unstructured":"Chang C.; Lin H.; Dysbiosis in gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2016,30(1),3-15","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/nm.4185","volume":"22","author":"Schroeder B.O.","year":"2016","unstructured":"Schroeder B.O.; B\u00e4ckhed F.; Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 2016,22(10),1079-1089","journal-title":"Nat Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.nrl.2015.07.005","volume":"32","author":"Castillo-\u00c1lvarez F.","year":"2017","unstructured":"Castillo-\u00c1lvarez F.; Marzo-Sola M.E.; Role of intestinal microbiota in the development of multiple sclerosis. Neurologia 2017,32(3),175-184","journal-title":"Neurologia"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/NMC.0000000000000373","volume":"42","author":"Dunn A.B.","year":"2017","unstructured":"Dunn A.B.; Jordan S.; Baker B.J.; Carlson N.S.; The maternal infant microbiome: considerations for labor and birth. MCN Am J Matern Child Nurs 2017,42(6),318-325","journal-title":"MCN Am J Matern Child Nurs"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ebiom.2014.11.004","volume":"1","author":"Goedert J.J.","year":"2014","unstructured":"Goedert J.J.; Hua X.; Yu G.; Shi J.; Diversity and composition of the adult fecal microbiome associated with history of cesarean birth or appendectomy: Analysis of the American Gut Project. EBioMedicine 2014,1(2-3),167-172","journal-title":"EBioMedicine"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40035-019-0175-7","volume":"8","author":"Haikal C.","year":"2019","unstructured":"Haikal C.; Chen Q.Q.; Li J.Y.; Microbiome changes: an indicator of Parkinson\u2019s disease? Transl Neurodegener 2019,8,38","journal-title":"Transl Neurodegener"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"11971","DOI":"10.1073\/pnas.1002601107","volume":"107","author":"Dominguez-Bello M.G.","year":"2010","unstructured":"Dominguez-Bello M.G.; Costello E.K.; Contreras M.; Magris M.; Hidalgo G.; Fierer N.; Knight R.; Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010,107(26),11971-11975","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.tins.2016.09.002","volume":"39","author":"Sarkar A.","year":"2016","unstructured":"Sarkar A.; Lehto S.M.; Harty S.; Dinan T.G.; Cryan J.F.; Burnet P.W.J.; Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends Neurosci 2016,39(11),763-781","journal-title":"Trends Neurosci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev-pharmtox-010919-023628","volume":"60","author":"Long-Smith C.","year":"2020","unstructured":"Long-Smith C.; O\u2019Riordan K.J.; Clarke G.; Stanton C.; Dinan T.G.; Cryan J.F.; Microbiota-Gut-Brain Axis: New therapeutic opportunities. Annu Rev Pharmacol Toxicol 2020,60,477-502","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/1570159X15666170915141036","volume":"16","author":"Kim Y.K.","year":"2018","unstructured":"Kim Y.K.; Shin C.; The Microbiota-Gut-Brain axis in neuropsychiatric disorders: pathophysiological mechanisms and novel treatments. Curr Neuropharmacol 2018,16(5),559-573 https:\/\/dx.doi.org\/10.2174%2F1570159X15666170915141036","journal-title":"Curr Neuropharmacol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ynstr.2016.03.001","volume":"4","author":"Rea K.","year":"2016","unstructured":"Rea K.; Dinan T.G.; Cryan J.F.; The microbiome: A key regulator of stress and neuroinflammation. Neurobiol Stress 2016,4,23-33","journal-title":"Neurobiol Stress"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1136\/gutjnl-2013-305690","volume":"63","author":"Vanuytsel T.","year":"2014","unstructured":"Vanuytsel T.; van Wanrooy S.; Vanheel H.; Vanormelingen C.; Verschueren S.; Houben E.; Salim Rasoel S.; T\u03ccth J.; Holvoet L.; Farr\u00e9 R.; Van Oudenhove L.; Boeckxstaens G.; Verbeke K.; Tack J.; Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut 2014,63(8),1293-1299","journal-title":"Gut"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1365-2982.2012.01928.x","volume":"24","author":"Alonso C.","year":"2012","unstructured":"Alonso C.; Guilarte M.; Vicario M.; Ramos L.; Rezzi S.; Mart\u00ednez C.; Lobo B.; Martin F.P.; Pigrau M.; Gonz\u00e1lez-Castro A.M.; Gallart M.; Malagelada J.R.; Azpiroz F.; Kochhar S.; Santos J.; Acute experimental stress evokes a differential gender-determined increase in human intestinal macromolecular permeability. Neurogastroenterol Motil e348-e3492012,24(8),740-746","journal-title":"Neurogastroenterol Motil"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.neuron.2019.02.008","volume":"101","author":"F\u00fclling C.","year":"2019","unstructured":"F\u00fclling C.; Dinan T.G.; Cryan J.F.; Gut microbe to brain signaling: what happens in vagus. Neuron 2019,101(6),998-1002","journal-title":"Neuron"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2174\/1381612053381684","volume":"11","author":"Banks W.A.","year":"2005","unstructured":"Banks W.A.; Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des 2005,11(8),973-984","journal-title":"Curr Pharm Des"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fneur.2019.00232","volume":"10","author":"Fuzzati-Armentero M.T.","year":"2019","unstructured":"Fuzzati-Armentero M.T.; Cerri S.; Blandini F.; Peripheral-Central neuroimmune crosstalk in parkinson\u2019s disease: what do patients and animal models tell us? Front Neurol 2019,10,232 https:\/\/dx.doi.org\/10.3389%2Ffneur.2019.00232","journal-title":"Front Neurol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","volume":"21","author":"Mulak A.","year":"2015","unstructured":"Mulak A.; Bonaz B.; Brain-gut-microbiota axis in Parkinson\u2019s disease. World J Gastroenterol 2015,21(37),10609-10620","journal-title":"World J Gastroenterol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.parkreldis.2015.02.004","volume":"21","author":"Cassani E.","year":"2015","unstructured":"Cassani E.; Barichella M.; Cancello R.; Cavanna F.; Iorio L.; Cereda E.; Bolliri C.; Zampella M.P.; Bianchi F.; Cestaro B.; Pezzoli G.; Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson\u2019s disease. Parkinsonism Relat Disord 2015,21(4),389-393","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","volume":"44","author":"Aho V.T.E.","year":"2019","unstructured":"Aho V.T.E.; Pereira P.A.B.; Voutilainen S.; Paulin L.; Pekkonen E.; Auvinen P.; Scheperjans F.; Gut microbiota in Parkinson\u2019s disease: Temporal stability and relations to disease progression. EBioMedicine 2019,44,691-707","journal-title":"EBioMedicine"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","volume":"34","author":"Barichella M.","year":"2019","unstructured":"Barichella M.; Severgnini M.; Cilia R.; Cassani E.; Bolliri C.; Caronni S.; Ferri V.; Cancello R.; Ceccarani C.; Faierman S.; Pinelli G.; De Bellis G.; Zecca L.; Cereda E.; Consolandi C.; Pezzoli G.; Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism. Mov Disord 2019,34(3),396-405","journal-title":"Mov Disord"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"Scheperjans F.","year":"2015","unstructured":"Scheperjans F.; Aho V.; Pereira P.A.B.; Koskinen K.; Paulin L.; Pekkonen E.; Haapaniemi E.; Kaakkola S.; Eerola-Rautio J.; Pohja M.; Kinnunen E.; Murros K.; Auvinen P.; Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 2015,30(3),350-358","journal-title":"Mov Disord"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","volume":"70","author":"Qian Y.","year":"2018","unstructured":"Qian Y.; Yang X.; Xu S.; Wu C.; Song Y.; Qin N.; Chen S.D.; Xiao Q.; Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease. Brain Behav Immun 2018,70,194-202","journal-title":"Brain Behav Immun"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142164","volume":"10","author":"Hasegawa S.","year":"2015","unstructured":"Hasegawa S.; Goto S.; Tsuji H.; Okuno T.; Asahara T.; Nomoto K.; Shibata A.; Fujisawa Y.; Minato T.; Okamoto A.; Ohno K.; Hirayama M.; Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson\u2019s disease. PLoS One 2015,10(11)","journal-title":"PLoS One"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"Keshavarzian A.","year":"2015","unstructured":"Keshavarzian A.; Green S.J.; Engen P.A.; Voigt R.M.; Naqib A.; Forsyth C.B.; Mutlu E.; Shannon K.M.; Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord 2015,30(10),1351-1360","journal-title":"Mov Disord"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","volume":"162","author":"Petrov V.A.","year":"2017","unstructured":"Petrov V.A.; Saltykova I.V.; Zhukova I.A.; Alifirova V.M.; Zhukova N.G.; Dorofeeva Y.B.; Tyakht A.V.; Kovarsky B.A.; Alekseev D.G.; Kostryukova E.S.; Mironova Y.S.; Izhboldina O.P.; Nikitina M.A.; Perevozchikova T.V.; Fait E.A.; Babenko V.V.; Vakhitova M.T.; Govorun V.M.; Sazonov A.E.; Analysis of gut microbiota in patients with parkinson\u2019s disease. Bull Exp Biol Med 2017,162(6),734-737","journal-title":"Bull Exp Biol Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1369\/jhc.2009.953539","volume":"57","author":"Barajon I.","year":"2009","unstructured":"Barajon I.; Serrao G.; Arnaboldi F.; Opizzi E.; Ripamonti G.; Balsari A.; Rumio C.; Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem 2009,57(11),1013-1023 https:\/\/dx.doi.org\/10.1369%2Fjhc.2009.953539","journal-title":"J Histochem Cytochem"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/j.gastro.2013.08.047","volume":"145","year":"2013","unstructured":"Brun p Giron M.C. Qesari M. Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. Gastroenterology 2013,145,1323-1333","journal-title":"Gastroenterology"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000336510","volume":"98","author":"Sudo N.","year":"2012","unstructured":"Sudo N.; Role of microbiome in regulating the HPA axis and its relevance to allergy. Chem Immunol Allergy 2012,98,163-175","journal-title":"Chem Immunol Allergy"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","volume":"2014","author":"De V.F.","year":"2014","unstructured":"De V.F.; Kovatcheva-Datchary P.; Goncalves D.; Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014,2014(156),84-96","journal-title":"Cell"},{"key":"ref=59","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.12.012","volume":"135","author":"Dodiya H.B.","year":"2020","unstructured":"Dodiya H.B.; Forsyth C.B.; Voigt R.M.; Engen P.A.; Patel J.; Shaikh M.; Green S.J.; Naqib A.; Roy A.; Kordower J.H.; Pahan K.; Shannon K.M.; Keshavarzian A.; Chronic stress-induced gut dysfunction exacerbates Parkinson\u2019s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson\u2019s disease. Neurobiol Dis 2020,135","journal-title":"Neurobiol Dis"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/FBP.0000000000000389","volume":"29","author":"Morais L.H.","year":"2018","unstructured":"Morais L.H.; Hara D.B.; Bicca M.A.; Poli A.; Takahashi R.N.; Early signs of colonic inflammation, intestinal dysfunction, and olfactory impairments in the rotenone-induced mouse model of Parkinson\u2019s disease. Behav Pharmacol 2018,29,199-210","journal-title":"Behav Pharmacol"},{"key":"ref=61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"Pan-Montojo F.","year":"2010","unstructured":"Pan-Montojo F.; Anichtchik O.; Dening Y.; Knels L.; Pursche S.; Jung R.; Jackson S.; Gille G.; Spillantini M.G.; Reichmann H.; Funk R.H.; Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 2010,5(1)","journal-title":"PLoS One"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3920\/BM2017.0202","volume":"9","author":"Perez-Pardo P.","year":"2018","unstructured":"Perez-Pardo P.; Dodiya H.B.; Engen P.A.; Naqib A.; Forsyth C.B.; Green S.J.; Garssen J.; Keshavarzian A.; Kraneveld A.D.; Gut bacterial composition in a mouse model of Parkinson\u2019s disease. Benef Microbes 2018,9(5),799-814","journal-title":"Benef Microbes"},{"key":"ref=63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"Forsyth C.B.","year":"2011","unstructured":"Forsyth C.B.; Shannon K.M.; Kordower J.H.; Voigt R.M.; Shaikh M.; Jaglin J.A.; Estes J.D.; Dodiya H.B.; Keshavarzian A.; Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS One 2011,6(12)","journal-title":"PLoS One"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fnbeh.2017.00009","volume":"11","author":"Noble E.E.","year":"2017","unstructured":"Noble E.E.; Hsu T.M.; Kanoski S.E.; Gut to brain dysbiosis: mechanisms linking western diet consumption, the microbiome, and cognitive impairment. Front Behav Neurosci 2017,11,9","journal-title":"Front Behav Neurosci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nri3430","volume":"13","author":"Kamada N.","year":"2013","unstructured":"Kamada N.; Seo S.U.; Chen G.Y.; N\u00fa\u00f1ez G.; Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013,13(5),321-335","journal-title":"Nat Rev Immunol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-012-0949-9","volume":"123","author":"Berer K.","year":"2012","unstructured":"Berer K.; Krishnamoorthy G.; Commensal gut flora and brain autoimmunity: a love or hate affair? Acta Neuropathol 2012,123(5),639-651","journal-title":"Acta Neuropathol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1111\/j.1460-9568.2005.04483.x","volume":"22","author":"Stolp H.B.","year":"2005","unstructured":"Stolp H.B.; Dziegielewska K.M.; Ek C.J.; Potter A.M.; Saunders N.R.; Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat. Eur J Neurosci 2005,22(11),2805-2816","journal-title":"Eur J Neurosci"},{"key":"ref=68","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/469046","volume":"2011","author":"Stolp H.B.","year":"2011","unstructured":"Stolp H.B.; Johansson P.A.; Habgood M.D.; Dziegielewska K.M.; Saunders N.R.; Ek C.J.; Effects of neonatal systemic inflammation on blood-brain barrier permeability and behaviour in juvenile and adult rats. Cardiovasc Psychiatry Neurol 2011,2011 https:\/\/dx.doi.org\/10.1155%2F2011%2F469046","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"ref=69","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6323","volume":"364","author":"Maini Rekdal V.","year":"2019","unstructured":"Maini Rekdal V.; Bess E.N.; Bisanz J.E.; Turnbaugh P.J.; Balskus E.P.; Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science 2019,364(6445)","journal-title":"Science"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","volume":"10","author":"van Kessel S.P.","year":"2019","unstructured":"van Kessel S.P.; Frye A.K.; El-Gendy A.O.; Castejon M.; Keshavarzian A.; van Dijk G.; El Aidy S.; Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease. Nat Commun 2019,10(1),310","journal-title":"Nat Commun"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3988\/jcn.2017.13.2.181","volume":"13","author":"Mridula K.R.","year":"2017","unstructured":"Mridula K.R.; Borgohain R.; Chandrasekhar Reddy V.; Bandaru V.; Ch.; Suryaprabha, T. Association of Helicobacter pylori with Parkinson\u2019s Disease. J Clin Neurol 2017,13(2),181-186","journal-title":"J Clin Neurol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.parkreldis.2014.02.019","volume":"20","author":"Tan A.H.","year":"2014","unstructured":"Tan A.H.; Mahadeva S.; Thalha A.M.; Gibson P.R.; Kiew C.K.; Yeat C.M.; Ng S.W.; Ang S.P.; Chow S.K.; Tan C.T.; Yong H.S.; Marras C.; Fox S.H.; Lim S.Y.; Small intestinal bacterial overgrowth in Parkinson\u2019s disease. Parkinsonism Relat Disord 2014,20(5),535-540","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/mds.23566","volume":"26","author":"Gabrielli M.","year":"2011","unstructured":"Gabrielli M.; Bonazzi P.; Scarpellini E.; Bendia E.; Lauritano E.C.; Fasano A.; Ceravolo M.G.; Capecci M.; Rita Bentivoglio A.; Provinciali L.; Tonali P.A.; Gasbarrini A.; Prevalence of small intestinal bacterial overgrowth in Parkinson\u2019s disease. Mov Disord 2011,26(5),889-892","journal-title":"Mov Disord"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1757-4749-5-23","volume":"5","author":"Lopetuso L.R.","year":"2013","unstructured":"Lopetuso L.R.; Scaldaferri F.; Petito V.; Gasbarrini A.; Commensal Clostridia: leading players in the maintenance of gut homeostasis. Gut Pathog 2013,5(1),23","journal-title":"Gut Pathog"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbr.2014.11.002","volume":"279","author":"von Wrangel C.","year":"2015","unstructured":"von Wrangel C.; Schwabe K.; John N.; Krauss J.K.; Alam M.; The rotenone-induced rat model of Parkinson\u2019s disease: behavioral and electrophysiological findings. Behav Brain Res 2015,279,52-61","journal-title":"Behav Brain Res"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jneuroim.2017.06.004","volume":"310","author":"Caggiu E.","year":"2017","unstructured":"Caggiu E.; Paulus K.; Galleri G.; Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson\u2019s disease. J Neuroimmonulogy 2017,310,26-31","journal-title":"J Neuroimmonulogy"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"Sampson T.R.","year":"2016","unstructured":"Sampson T.R.; Debelius J.W.; Thron T.; Janssen S.; Shastri G.G.; Ilhan Z.E.; Challis C.; Schretter C.E.; Rocha S.; Gradinaru V.; Chesselet M.F.; Keshavarzian A.; Shannon K.M.; Krajmalnik-Brown R.; Wittung-Stafshede P.; Knight R.; Mazmanian S.K.; Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s Disease. Cell 2016,167(6),1469-1480.e12","journal-title":"Cell"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.27105","volume":"33","author":"Heintz-Buschart A.","year":"2018","unstructured":"Heintz-Buschart A.; Pandey U.; Wicke T.; The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movment sleep behavior disorder. Mov Disord 2018,33(1),88-98","journal-title":"Mov Disord"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"Lin C.H.","year":"2019","unstructured":"Lin C.H.; Chen C.C.; Chiang H.L.; Liou J.M.; Chang C.M.; Lu T.P.; Chuang E.Y.; Tai Y.C.; Cheng C.; Lin H.Y.; Wu M.S.; Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J Neuroinflammation 2019,16(1),129","journal-title":"J Neuroinflammation"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","volume":"1667","author":"Hopfner F.","year":"2017","unstructured":"Hopfner F.; K\u00fcnstner A.; M\u00fcller S.H.; K\u00fcnzel S.; Zeuner K.E.; Margraf N.G.; Deuschl G.; Baines J.F.; Kuhlenb\u00e4umer G.; Gut microbiota in Parkinson disease in a northern German cohort. Brain Res 2017,1667,41-45","journal-title":"Brain Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","volume":"60","author":"Li W.","year":"2017","unstructured":"Li W.; Wu X.; Hu X.; Wang T.; Liang S.; Duan Y.; Jin F.; Qin B.; Structural changes of gut microbiota in Parkinson\u2019s disease and its correlation with clinical features. Sci China Life Sci 2017,60(11),1223-1233","journal-title":"Sci China Life Sci"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"Hill-Burns E.M.","year":"2017","unstructured":"Hill-Burns E.M.; Debelius J.W.; Morton J.T.; Wissemann W.T.; Lewis M.R.; Wallen Z.D.; Peddada S.D.; Factor S.A.; Molho E.; Zabetian C.P.; Knight R.; Payami H.; Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 2017,32(5),739-749","journal-title":"Mov Disord"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"Bedarf J.R.","year":"2017","unstructured":"Bedarf J.R.; Hildebrand F.; Coelho L.P.; Sunagawa S.; Bahram M.; Goeser F.; Bork P.; W\u00fcllner U.; Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med 2017,9(1),39","journal-title":"Genome Med"},{"key":"ref=84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218252","volume":"14","author":"Mihaila D.","year":"2019","unstructured":"Mihaila D.; Donegan J.; Barns S.; LaRocca D.; Du Q.; Zheng D.; Vidal M.; Neville C.; Uhlig R.; Middleton F.A.; The oral microbiome of early stage Parkinson\u2019s disease and its relationship with functional measures of motor and non-motor function. PLoS One 2019,14(6)","journal-title":"PLoS One"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"Unger M.M.","year":"2016","unstructured":"Unger M.M.; Spiegel J.; Dillmann K.U.; Grundmann D.; Philippeit H.; B\u00fcrmann J.; Fa\u00dfbender K.; Schwiertz A.; Sch\u00e4fer K.H.; Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 2016,32,66-72","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1007\/s12035-018-0937-8","volume":"55","author":"Garrido-Gil P.","year":"2018","unstructured":"Garrido-Gil P.; Rodriguez-Perez A.I.; Dominguez-Meijide A.; Guerra M.J.; Labandeira-Garcia J.L.; Bidirectional neural interaction between central dopaminergic and gut lesions in parkinson\u2019s disease models. Mol Neurobiol 2018,55(9),7297-7316","journal-title":"Mol Neurobiol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11940-018-0539-9","volume":"20","author":"Pfeiffer R.F.","year":"2018","unstructured":"Pfeiffer R.F.; Gastrointestinal dysfunction in Parkinson\u2019s Disease. Curr Treat Options Neurol 2018,20(12),54","journal-title":"Curr Treat Options Neurol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.3748\/wjg.v22.i25.5742","volume":"22","author":"Mukherjee A.","year":"2016","unstructured":"Mukherjee A.; Biswas A.; Das S.K.; Gut dysfunction in Parkinson\u2019s disease. World J Gastroenterol 2016,22(25),5742-5752","journal-title":"World J Gastroenterol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12017-019-08539-5","volume":"21","author":"Kishimoto Y.","year":"2019","unstructured":"Kishimoto Y.; Zhu W.; Hosoda W.; Sen J.M.; Mattson M.P.; Chronic mild gut inflammation accelerates brain neuropathology and motor dysfunction in \u03b1-synuclein mutant mice. Neuromolecular Med 2019,21(3),239-249","journal-title":"Neuromolecular Med"},{"key":"ref=90","author":"Zheng W.","year":"2019","unstructured":"Zheng W.; He R.; Yan Z.; Huang Y.; Huang W.; Cai Z.; Su Y.; Liu S.; Deng Y.; Wang Q.; Xie H.;  Regulation of immune-driven pathogenesis in parkinson\u2019s disease by gut microbiota  Brain, Behavior, and Immunity 2019 https:\/\/dx.doi.org\/10.12938%2Fbmfh.19-002","journal-title":"Regulation of immune-driven pathogenesis in parkinson\u2019s disease by gut microbiota  Brain, Behavior, and Immunity"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-physiol-021115-105439","volume":"78","author":"Gribble F.M.","year":"2016","unstructured":"Gribble F.M.; Reimann F.; Enteroendocrine cells: chemosensors in the intestinal epithelium. Annu Rev Physiol 2016,78,277-299","journal-title":"Annu Rev Physiol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev.pathol.4.110807.092135","volume":"5","author":"Marchiando A.M.","year":"2010","unstructured":"Marchiando A.M.; Graham W.V.; Turner J.R.; Epithelial barriers in homeostasis and disease. Annu Rev Pathol 2010,5,119-144","journal-title":"Annu Rev Pathol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00018-012-1070-x","volume":"70","author":"Suzuki T.","year":"2013","unstructured":"Suzuki T.; Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 2013,70(4),631-659","journal-title":"Cell Mol Life Sci"},{"key":"ref=94","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13366","volume":"30","author":"Bhattarai Y.","year":"2018","unstructured":"Bhattarai Y.; Microbiota-gut-brain axis: Interaction of gut microbes and their metabolites with host epithelial barriers. Neurogastroenterol Motil 2018,30(6)","journal-title":"Neurogastroenterol Motil"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1866-1955-4-19","volume":"4","author":"Dichter G.S.","year":"2012","unstructured":"Dichter G.S.; Damiano C.A.; Allen J.A.; Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. J Neurodev Disord 2012,4(1),19","journal-title":"J Neurodev Disord"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nbd.2009.07.031","volume":"37","author":"Banks W.A.","year":"2010","unstructured":"Banks W.A.; Erickson M.A.; The blood-brain barrier and immune function and dysfunction. Neurobiol Dis 2010,37(1),26-32","journal-title":"Neurobiol Dis"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrn3346","volume":"13","author":"Cryan J.F.","year":"2012","unstructured":"Cryan J.F.; Dinan T.G.; Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012,13(10),701-712","journal-title":"Nat Rev Neurosci"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","volume":"36","author":"Foster J.A.","year":"2013","unstructured":"Foster J.A.; McVey Neufeld K.A.; Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 2013,36(5),305-312","journal-title":"Trends Neurosci"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3389\/fmicb.2016.01934","volume":"7","author":"Mazzoli R.","year":"2016","unstructured":"Mazzoli R.; Pessione E.; The neuro-endocrinological role of microbial glutamate and gaba signaling. Front Microbiol 2016,7,1934 https:\/\/dx.doi.org\/10.3389%2Ffmicb.2016.01934","journal-title":"Front Microbiol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/bies.201100024","volume":"33","author":"Lyte M.","year":"2011","unstructured":"Lyte M.; Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probiotics. BioEssays 2011,33(8),574-581","journal-title":"BioEssays"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrgastro.2013.105","volume":"10","author":"Mawe G.","year":"2013","unstructured":"Mawe G.; Hoffman J.; Serotonin signaling in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2013,10,473-486","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=102","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a020602","volume":"7","author":"Silver J.","year":"2014","unstructured":"Silver J.; Schwab M.E.; Popovich P.G.; Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia. Cold Spring Harb Perspect Biol 2014,7(3)","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=103","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-0897-4","author":"Lyte M.","year":"2014","unstructured":"Lyte M.; John Cryan F.;  Microbial Endocrinology: The Microbiota Gut-Brain Axis in Health and Disease 2014","journal-title":"Microbial Endocrinology: The Microbiota Gut-Brain Axis in Health and Disease"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/mds.25736","volume":"29","author":"Kelly L.P.","year":"2014","unstructured":"Kelly L.P.; Carvey P.M.; Keshavarzian A.; Shannon K.M.; Shaikh M.; Bakay R.A.; Kordower J.H.; Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson\u2019s disease. Mov Disord 2014,29(8),999-1009","journal-title":"Mov Disord"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12035-012-8267-8","volume":"47","author":"Lema Tom\u00e9 C.M.","year":"2013","unstructured":"Lema Tom\u00e9 C.M.; Tyson T.; Rey N.L.; Grathwohl S.; Britschgi M.; Brundin P.; Inflammation and \u03b1-synuclein\u2019s prion-like behavior in Parkinson\u2019s disease--is there a link? Mol Neurobiol 2013,47(2),561-574","journal-title":"Mol Neurobiol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1742-2094-8-166","volume":"8","author":"Couch Y.","year":"2011","unstructured":"Couch Y.; Alvarez-Erviti L.; Sibson N.R.; Wood M.J.; Anthony D.C.; The acute inflammatory response to intranigral \u03b1-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation. J Neuroinflammation 2011,8,166","journal-title":"J Neuroinflammation"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","volume":"62","author":"Sui Y.T.","year":"2014","unstructured":"Sui Y.T.; Bullock K.M.; Erickson M.A.; Zhang J.; Banks W.A.; Alpha synuclein is transported into and out of the brain by the blood-brain barrier. Peptides 2014,62,197-202","journal-title":"Peptides"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.nbd.2011.10.014","volume":"46","author":"Cersosimo M.G.","year":"2012","unstructured":"Cersosimo M.G.; Benarroch E.E.; Pathological correlates of gastrointestinal dysfunction in Parkinson\u2019s disease. Neurobiol Dis 2012,46(3),559-564","journal-title":"Neurobiol Dis"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/mds.23305","volume":"25","author":"Kingsbury A.E.","year":"2010","unstructured":"Kingsbury A.E.; Bandopadhyay R.; Silveira-Moriyama L.; Ayling H.; Kallis C.; Sterlacci W.; Maeir H.; Poewe W.; Lees A.J.; Brain stem pathology in Parkinson\u2019s disease: an evaluation of the Braak staging model. Mov Disord 2010,25(15),2508-2515","journal-title":"Mov Disord"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.2174\/1568026620666200413091101]","volume":"20","author":"Chandra S.","year":"2020","unstructured":"Chandra S.; Alam M.T.; Dey J.; Chakrapani P S; B.; Ray, U.; Srivastava, A.K.; Gandhi, S.; Tripathi, P.P. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders. Curr Top Med Chem 2020,20(13),1142-1153","journal-title":"Curr Top Med Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1515\/revneuro-2019-0095","volume":"31","author":"Sz\u0151ke H.","year":"2020","unstructured":"Sz\u0151ke H.; Kov\u00e1cs Z.; B\u00f3kkon I.; Vagedes J.; Szab\u00f3 A.E.; Hegyi G.; Sterner M.G.; Kiss \u00c1.; Kap\u00f3cs G.; Gut dysbiosis and serotonin: intestinal 5-HT as a ubiquitous membrane permeability regulator in host tissues, organs, and the brain. Rev Neurosci 2020,31(4),415-425","journal-title":"Rev Neurosci"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/advances\/nmz127","volume":"11","author":"Gao K.","year":"2020","unstructured":"Gao K.; Mu C.L.; Farzi A.; Zhu W.Y.; Tryptophan metabolism: a link between the gut microbiota and brain. Adv Nutr 2020,11(3),709-723","journal-title":"Adv Nutr"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmgh.2018.04.003","volume":"6","author":"Martin C.R.","year":"2018","unstructured":"Martin C.R.; Osadchiy V.; Kalani A.; Mayer E.A.; The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol 2018,6(2),133-148 https:\/\/dx.doi.org\/10.1016%2Fj.jcmgh.2018.04.003","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12974-019-1434-3","volume":"16","author":"Ma Q.","year":"2019","unstructured":"Ma Q.; Xing C.; Long W.; Wang H.Y.; Liu Q.; Wang R.F.; Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. J Neuroinflammation 2019,16(1),53","journal-title":"J Neuroinflammation"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/19490976.2019.1638722","volume":"11","author":"Parker A.","year":"2020","unstructured":"Parker A.; Fonseca S.; Carding S.R.; Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microbes 2020,11(2),135-157","journal-title":"Gut Microbes"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3390\/ijms19061689","volume":"19","author":"Caputi V.","year":"2018","unstructured":"Caputi V.; Giron M.C.; Microbiome-gut-brain axis and toll-like receptors in Parkinson\u2019s disease. Int J Mol Sci 2018,19(6),1689","journal-title":"Int J Mol Sci"},{"key":"ref=117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002785","volume":"8","author":"Kubinak J.L.","year":"2012","unstructured":"Kubinak J.L.; Round J.L.; Toll-like receptors promote mutually beneficial commensal-host interactions. PLoS Pathog 2012,8(7)","journal-title":"PLoS Pathog"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mcn.2015.03.018","volume":"68","author":"Brun P.","year":"2015","unstructured":"Brun P.; Gobbo S.; Caputi V.; Spagnol L.; Schirato G.; Pasqualin M.; Levorato E.; Pal\u00f9 G.; Giron M.C.; Castagliuolo I.; Toll like receptor-2 regulates production of glial-derived neurotrophic factors in murine intestinal smooth muscle cells. Mol Cell Neurosci 2015,68,24-35","journal-title":"Mol Cell Neurosci"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.tins.2011.02.005","volume":"34","author":"Okun E.","year":"2011","unstructured":"Okun E.; Griffioen K.J.; Mattson M.P.; Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 2011,34(5),269-281","journal-title":"Trends Neurosci"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/ncomms2534","volume":"4","author":"Kim C.","year":"2013","unstructured":"Kim C.; Ho D.H.; Suk J.E.; You S.; Michael S.; Kang J.; Joong Lee S.; Masliah E.; Hwang D.; Lee H.J.; Lee S.J.; Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun 2013,4,1562","journal-title":"Nat Commun"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"ra45","DOI":"10.1126\/scisignal.2005965","volume":"8","author":"Daniele S.G.","year":"2015","unstructured":"Daniele S.G.; B\u00e9raud D.; Davenport C.; Cheng K.; Yin H.; Maguire-Zeiss K.A.; Activation of MyD88-dependent TLR1\/2 signaling by misfolded \u03b1-synuclein, a protein linked to neurodegenerative disorders. Sci Signal 2015,8(376),ra45","journal-title":"Sci Signal"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/S1353-8020(11)70008-6","volume":"18","author":"B\u00e9raud D.","year":"2012","unstructured":"B\u00e9raud D.; Maguire-Zeiss K.A.; Misfolded \u03b1-synuclein and Toll-like receptors: therapeutic targets for Parkinson\u2019s disease. Parkinsonism Relat Disord 2012,18(Suppl. 1),S17-S20","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","volume":"61","author":"Fellner L.","year":"2013","unstructured":"Fellner L.; Irschick R.; Schanda K.; Reindl M.; Klimaschewski L.; Poewe W.; Wenning G.K.; Stefanova N.; Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia. Glia 2013,61(3),349-360","journal-title":"Glia"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/srep01393","volume":"3","author":"Noelker C.","year":"2013","unstructured":"Noelker C.; Morel L.; Lescot T.; Osterloh A.; Alvarez-Fischer D.; Breloer M.; Henze C.; Depboylu C.; Skrzydelski D.; Michel P.P.; Dodel R.C.; Lu L.; Hirsch E.C.; Hunot S.; Hartmann A.; Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Sci Rep 2013,3,1393","journal-title":"Sci Rep"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Yan Y.","year":"2015","unstructured":"Yan Y.; Jiang W.; Liu L.; Wang X.; Ding C.; Tian Z.; Zhou R.; Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 2015,160(1-2),62-73","journal-title":"Cell"},{"key":"ref=126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"Codolo G.","year":"2013","unstructured":"Codolo G.; Plotegher N.; Pozzobon T.; Brucale M.; Tessari I.; Bubacco L.; de Bernard M.; Triggering of inflammasome by aggregated \u03b1-synuclein, an inflammatory response in synucleinopathies. PLoS One 2013,8(1)","journal-title":"PLoS One"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev-med-050715-104343","volume":"69","author":"Labzin L.I.","year":"2018","unstructured":"Labzin L.I.; Heneka M.T.; Latz E.; Innate immunity and neurodegeneration. Annu Rev Med 2018,69,437-449","journal-title":"Annu Rev Med"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"27","DOI":"10.20517\/2347-8659.2015.28","volume":"3","author":"Rietdijk C.D.","year":"2016","unstructured":"Rietdijk C.D.; van Wezel R.J.; Garssen J.; Kraneveld A.D.; Neuronal toll-like receptors and neuro-immunity in Parkinson\u2019s disease, Alzheimer\u2019s disease and stroke. Neuroimmunol Neuroinflamm 2016,3,27-37","journal-title":"Neuroimmunol Neuroinflamm"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tips.2012.07.002","volume":"33","author":"Drouin-Ouellet J.","year":"2012","unstructured":"Drouin-Ouellet J.; Cicchetti F.; Inflammation and neurodegeneration: the story \u2018retolled\u2019. Trends Pharmacol Sci 2012,33(10),542-551","journal-title":"Trends Pharmacol Sci"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/bies.201100042","volume":"33","author":"Diamond B.","year":"2011","unstructured":"Diamond B.; Huerta P.T.; Tracey K.; Volpe B.T.; It takes guts to grow a brain: Increasing evidence of the important role of the intestinal microflora in neuro- and immune-modulatory functions during development and adulthood. BioEssays 2011,33(8),588-591","journal-title":"BioEssays"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1073\/pnas.1010529108","volume":"108","author":"Diaz Heijtz R.","year":"2011","unstructured":"Diaz Heijtz R.; Wang S.; Anuar F.; Qian Y.; Bj\u00f6rkholm B.; Samuelsson A.; Hibberd M.L.; Forssberg H.; Pettersson S.; Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 2011,108(7),3047-3052","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1089\/jmf.2014.7000","volume":"17","author":"Galland L.","year":"2014","unstructured":"Galland L.; The gut microbiome and the brain. J Med Food 2014,17(12),1261-1272 https:\/\/dx.doi.org\/10.1089%2Fjmf.2014.7000","journal-title":"J Med Food"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.ajpath.2011.04.013","volume":"179","author":"Stefanova N.","year":"2011","unstructured":"Stefanova N.; Fellner L.; Reindl M.; Masliah E.; Poewe W.; Wenning G.K.; Toll-like receptor 4 promotes \u03b1-synuclein clearance and survival of nigral dopaminergic neurons. Am J Pathol 2011,179(2),954-963","journal-title":"Am J Pathol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1017\/S0007114515004997","volume":"115","author":"Alizadeh A.","year":"2016","unstructured":"Alizadeh A.; Akbari P.; Difilippo E.; Schols H.A.; Ulfman L.H.; Schoterman M.H.; Garssen J.; Fink-Gremmels J.; Braber S.; The piglet as a model for studying dietary components in infant diets: effects of galacto-oligosaccharides on intestinal functions. Br J Nutr 2016,115(4),605-618","journal-title":"Br J Nutr"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.neuint.2013.10.006","volume":"63","author":"Savignac H.M.","year":"2013","unstructured":"Savignac H.M.; Corona G.; Mills H.; Chen L.; Spencer J.P.; Tzortzis G.; Burnet P.W.; Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine. Neurochem Int 2013,63(8),756-764","journal-title":"Neurochem Int"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3389\/fmicb.2016.00979","volume":"7","author":"Rivi\u00e8re A.","year":"2016","unstructured":"Rivi\u00e8re A.; Selak M.; Lantin D.; Leroy F.; De Vuyst L.; Bifidobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut. Front Microbiol 2016,7,979","journal-title":"Front Microbiol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"16050","DOI":"10.1073\/pnas.1102999108","volume":"108","author":"Bravo J.A.","year":"2011","unstructured":"Bravo J.A.; Forsythe P.; Chew M.V.; Escaravage E.; Savignac H.M.; Dinan T.G.; Bienenstock J.; Cryan J.F.; Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011,108(38),16050-16055 https:\/\/dx.doi.org\/10.1073%2Fpnas.1102999108","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"387","DOI":"10.15403\/jgld.2014.1121.234.elr","volume":"23","author":"Ojetti V.","year":"2014","unstructured":"Ojetti V.; Ianiro G.; Tortora A.; D\u2019Angelo G.; Di Rienzo T.A.; Bibb\u00f2 S.; Migneco A.; Gasbarrini A.; The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. J Gastrointestin Liver Dis 2014,23(4),387-391","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref=139","first-page":"117","volume":"57","author":"Cassani E.","year":"2011","unstructured":"Cassani E.; Privitera G.; Pezzoli G.; Pusani C.; Madio C.; Iorio L.; Barichella M.; Use of probiotics for the treatment of constipation in Parkinson\u2019s disease patients. Minerva Gastroenterol Dietol 2011,57(2),117-121","journal-title":"Minerva Gastroenterol Dietol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejphar.2016.04.024","volume":"785","author":"Hwang D.H.","year":"2016","unstructured":"Hwang D.H.; Kim J.A.; Lee J.Y.; Mechanisms for the activation of Toll-like receptor 2\/4 by saturated fatty acids and inhibition by docosahexaenoic acid. Eur J Pharmacol 2016,785,24-35","journal-title":"Eur J Pharmacol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biocel.2018.03.017","volume":"99","author":"Tang R.","year":"2018","unstructured":"Tang R.; Lin Y.M.; Liu H.X.; Wang E.S.; Neuroprotective effect of docosahexaenoic acid in rat traumatic brain injury model via regulation of TLR4\/NF-Kappa B signaling pathway. Int J Biochem Cell Biol 2018,99,64-71","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11481-011-9333-0","volume":"7","author":"Beamer C.A.","year":"2012","unstructured":"Beamer C.A.; Shepherd D.M.; Inhibition of TLR ligand- and interferon gamma-induced murine microglial activation by Panax notoginseng. J Neuroimmune Pharmacol 2012,7(2),465-476","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.biopha.2018.05.020","volume":"104","author":"Haddadi R.","year":"2018","unstructured":"Haddadi R.; Nayebi A.M.; Eyvari B.S.; Silymarin prevents apoptosis through inhibiting the Bax\/caspase-3 expression and suppresses toll like receptor-4 pathway in the SNc of 6-OHDA intoxicated rats. Biomed Pharmacother 2018,104,127-136","journal-title":"Biomed Pharmacother"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature15766","volume":"528","author":"Forslund K.","year":"2015","unstructured":"Forslund K.; Hildebrand F.; Nielsen T.; Falony G.; Le Chatelier E.; Sunagawa S.; Prifti E.; Vieira-Silva S.; Gudmundsdottir V.; Pedersen H.K.; Arumugam M.; Kristiansen K.; Voigt A.Y.; Vestergaard H.; Hercog R.; Costea P.I.; Kultima J.R.; Li J.; J\u00f8rgensen T.; Levenez F.; Dore J.; Nielsen H.B.; Brunak S.; Raes J.; Hansen T.; Wang J.; Ehrlich S.D.; Bork P.; Pedersen O.; MetaHIT consortium. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 2015,528(7581),262-266","journal-title":"Nature"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","volume":"65","author":"Imhann F.","year":"2016","unstructured":"Imhann F.; Bonder M.J.; Vich Vila A.; Fu J.; Mujagic Z.; Vork L.; Tigchelaar E.F.; Jankipersadsing S.A.; Cenit M.C.; Harmsen H.J.; Dijkstra G.; Franke L.; Xavier R.J.; Jonkers D.; Wijmenga C.; Weersma R.K.; Zhernakova A.; Proton pump inhibitors affect the gut microbiome. Gut 2016,65(5),740-748","journal-title":"Gut"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1053\/j.gastro.2015.06.043","volume":"149","author":"Freedberg D.E.","year":"2015","unstructured":"Freedberg D.E.; Toussaint N.C.; Chen S.P.; Ratner A.J.; Whittier S.; Wang T.C.; Wang H.H.; Abrams J.A.; Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology 2015,149(4),883-5.e9","journal-title":"Gastroenterology"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","volume":"65","author":"Jackson M.A.","year":"2016","unstructured":"Jackson M.A.; Goodrich J.K.; Maxan M.E.; Freedberg D.E.; Abrams J.A.; Poole A.C.; Sutter J.L.; Welter D.; Ley R.E.; Bell J.T.; Spector T.D.; Steves C.J.; Proton pump inhibitors alter the composition of the gut microbiota. Gut 2016,65(5),749-756","journal-title":"Gut"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"Maier L.","year":"2018","unstructured":"Maier L.; Pruteanu M.; Kuhn M.; Zeller G.; Telzerow A.; Anderson E.E.; Brochado A.R.; Fernandez K.C.; Dose H.; Mori H.; Patil K.R.; Bork P.; Typas A.; Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018,555(7698),623-628","journal-title":"Nature"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00213-018-5006-5","volume":"236","author":"Cussotto S.","year":"2019","unstructured":"Cussotto S.; Strain C.R.; Fouhy F.; Strain R.G.; Peterson V.L.; Clarke G.; Stanton C.; Dinan T.G.; Cryan J.F.; Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function. Psychopharmacology (Berl) 2019,236(5),1671-1685","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=150","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.83","volume":"3","author":"Davey K.J.","year":"2013","unstructured":"Davey K.J.; Cotter P.D.; O\u2019Sullivan O.; Crispie F.; Dinan T.G.; Cryan J.F.; O\u2019Mahony S.M.; Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry 2013,3 https:\/\/dx.doi.org\/10.1038%2Ftp.2013.83","journal-title":"Transl Psychiatry"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/182576","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/182576\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/182576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T14:14:07Z","timestamp":1640268847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/182576\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":150,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,12,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x18666200606233050","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-04-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}